Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Commentary

Commentary on “Hyperbaric Oxygen Therapy Improves Neurocognitive Functions and Symptoms of Post-COVID Condition: Randomized Controlled Trial”

Author(s): Júlia Leão Batista Simões, Geórgia de Carvalho Braga and Margarete Dulce Bagatini*

Volume 29, Issue 34, 2023

Published on: 22 November, 2023

Page: [2679 - 2683] Pages: 5

DOI: 10.2174/0113816128268472231106093239

Next »
[1]
Premraj L, Kannapadi NV, Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci 2022; 434: 120162.
[http://dx.doi.org/10.1016/j.jns.2022.120162] [PMID: 35121209]
[2]
Kjellberg A, Abdel-Halim L, Hassler A, et al. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): Protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial. BMJ Open 2022; 12(11): e061870.
[http://dx.doi.org/10.1136/bmjopen-2022-061870] [PMID: 36323462]
[3]
Zilberman-Itskovich S, Catalogna M, Sasson E, et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: Randomized controlled trial. Sci Rep 2022; 12(1): 11252.
[http://dx.doi.org/10.1038/s41598-022-15565-0] [PMID: 35821512]
[4]
Gottfried I, Schottlender N, Ashery U. Hyperbaric oxygen treatment-from mechanisms to cognitive improvement. Biomolecules 2021; 11(10): 1520.
[http://dx.doi.org/10.3390/biom11101520] [PMID: 34680155]
[5]
Hadanny A, Efrati S. The hyperoxic-hypoxic paradox. Biomolecules 2020; 10(6): 958.
[http://dx.doi.org/10.3390/biom10060958] [PMID: 32630465]
[6]
Hadanny A, Bechor Y, Catalogna M, et al. Hyperbaric oxygen therapy can induce neuroplasticity and significant clinical improvement in patients suffering from fibromyalgia with a history of childhood sexual abuse-randomized controlled trial. Front Psychol 2018; 9: 2495.
[http://dx.doi.org/10.3389/fpsyg.2018.02495] [PMID: 30618929]
[7]
Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID-mechanisms, risk factors, and management. BMJ 2021; 374(1648): n1648.
[http://dx.doi.org/10.1136/bmj.n1648] [PMID: 34312178]
[8]
Mairal E, Barberon B, Laine N, Coulange M, Guedj E. Reversible widespread brain 18F-FDG PET hypometabolism in chronic fatigue syndrome treated by hyperbaric oxygen therapy. Eur J Nucl Med Mol Imaging 2021; 48(5): 1680-1.
[http://dx.doi.org/10.1007/s00259-020-05122-0] [PMID: 33420913]
[9]
Robbins T, Gonevski M, Clark C, et al. Hyperbaric oxygen therapy for the treatment of long COVID: Early evaluation of a highly promising intervention. Clin Med (Lond) 2021; 21(6): e629-32.
[http://dx.doi.org/10.7861/clinmed.2021-0462] [PMID: 34862223]
[10]
Stefano GB. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med Sci Monit 2021; 27: e931447.
[http://dx.doi.org/10.12659/MSM.931447] [PMID: 33633106]
[11]
Vanderlind WM, Rabinovitz BB, Miao IY, et al. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: Implications for treatment. Curr Opin Psychiatry 2021; 34(4): 420-33.
[http://dx.doi.org/10.1097/YCO.0000000000000713] [PMID: 34016818]
[12]
Becker JH, Lin JJ, Doernberg M, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open 2021; 4(10): e2130645.
[http://dx.doi.org/10.1001/jamanetworkopen.2021.30645] [PMID: 34677597]
[13]
De Paepe B, Smet J, Baeken C, Van Oosterwijck J, Meeus M. A capital role for the brain’s insula in the diverse fibromyalgia-associated symptoms. Med Hypotheses 2020; 143: 110077.
[http://dx.doi.org/10.1016/j.mehy.2020.110077] [PMID: 32721793]
[14]
Curtis K, Katz J, Djaiani C, et al. Evaluation of a hyperbaric oxygen therapy intervention in individuals with fibromyalgia. Pain Med 2021; 22(6): 1324-32.
[http://dx.doi.org/10.1093/pm/pnaa416] [PMID: 33594439]
[15]
Kirby JP, Snyder J, Schuerer DJE, Peters JS, Bochicchio GV. Essentials of hyperbaric oxygen therapy: 2019 review. Mo Med 2019; 116(3): 176-9.
[PMID: 31527935]
[16]
Lind F. A pro/con review comparing the use of mono- and multiplace hyperbaric chambers for critical care. Diving Hyperb Med 2015; 45(1): 56-60.
[PMID: 25964041]
[17]
Lam G, Fontaine R, Ross FL, Chiu ES. Hyperbaric oxygen therapy: Exploring the clinical evidence. Adv Skin Wound Care 2017; 30(4): 181-90.
[http://dx.doi.org/10.1097/01.ASW.0000513089.75457.22] [PMID: 28301358]
[18]
Izquierdo-Alventosa R, Inglés M, Cortés-Amador S, et al. Comparative study of the effectiveness of a low-pressure hyperbaric oxygen treatment and physical exercise in women with fibromyalgia: Randomized clinical trial. Ther Adv Musculoskelet Dis 2020; 12: 1759720X20930493.
[http://dx.doi.org/10.1177/1759720X20930493]
[19]
Position Statement UHMS. UHMS Position Statement: Low-Pressure Fabric Hyperbaric Chambers Title: Low-Pressure Fabric Hyperbaric Chambers. 2017. Available online: https://www.uhms.org/images/Position-Statements/UHMS_Position_Statement_LP_chambers_revised.pdf [accessed on 19 April 2023].
[20]
Camporesi EM, Mascia MF, Thom SR. Handbook on hyperbaric medicine. Milan, Italy: Springer 1996; pp. 35-58.
[21]
Bennett MH, French C, Schnabel A, Wasiak J, Kranke P, Weibel S. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Libr 2015; 2016(1): CD005219.
[http://dx.doi.org/10.1002/14651858.CD005219.pub3] [PMID: 26709672]
[22]
Casillas S, Galindo A, Camarillo-Reyes LA, Varon J, Surani SR. Effectiveness of hyperbaric oxygenation versus normobaric oxygenation therapy in carbon monoxide poisoning: A systematic review. Cureus 2019; 11(10): e5916.
[http://dx.doi.org/10.7759/cureus.5916] [PMID: 31788375]
[23]
Jones MW, Wyatt HA. Hyperbaric, Physics. Treasure Island, FL, USA: StatPearls Publishing 2019.
[24]
Leach RM, Rees PJ, Wilmshurst P. ABC of oxygen: Hyperbaric oxygen therapy. BMJ 1998; 317(7166): 1140-3.
[http://dx.doi.org/10.1136/bmj.317.7166.1140] [PMID: 9784458]
[25]
Brugniaux JV, Coombs GB, Barak OF, Dujic Z, Sekhon MS, Ainslie PN. Highs and lows of hyperoxia: Physiological, performance, and clinical aspects. Am J Physiol Regul Integr Comp Physiol 2018; 315(1): R1-R27.
[http://dx.doi.org/10.1152/ajpregu.00165.2017] [PMID: 29488785]
[26]
Calabrese E. Hormesis: Path and progression to significance. Int J Mol Sci 2018; 19(10): 2871.
[http://dx.doi.org/10.3390/ijms19102871] [PMID: 30248927]
[27]
Camporesi EM, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med 2014; 41(3): 247-52.
[PMID: 24984320]
[28]
Longobardi P, Hoxha K, Perreca F. Is hyperbaric oxygen an effective treatment for the prevention of complications in SARS-CoV-2 asymptomatic patients? Infectious Microbes and Diseases 2021; 3(2): 109-11.
[http://dx.doi.org/10.1097/IM9.0000000000000064]
[29]
Chen W, Liang X, Nong Z, et al. The multiple applications and possible mechanisms of the hyperbaric oxygenation therapy. Med Chem 2019; 15(5): 459-71.
[http://dx.doi.org/10.2174/1573406415666181219101328] [PMID: 30569869]
[30]
DuBose KJ, Cooper JS. Hyperbaric Patient Selection. Treasure Island, FL, USA: StatPearls Publishing 2018.
[31]
Fife CE, Eckert KA, Carter MJ. An update on the appropriate role for hyperbaric oxygen: Indications and evidence. Plast Reconstr Surg 2016; 138(3S) (Suppl.): 107S-16S.
[http://dx.doi.org/10.1097/PRS.0000000000002714] [PMID: 27556750]
[32]
Zhang Y, Zhou Y, Jia Y, Wang T, Meng D. Adverse effects of hyperbaric oxygen therapy: A systematic review and meta-analysis. Front Med 2023; 10: 1160774.
[http://dx.doi.org/10.3389/fmed.2023.1160774] [PMID: 37275378]

Rights & Permissions Print Cite
Article Metrics
16
2
World Chronic Fatigue Syndrome Awareness Day
© 2024 Bentham Science Publishers | Privacy Policy